VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE
· Real-Time Price · USD
0.40
-1.04 (-72.22%)
At close: Jul 30, 2025, 3:59 PM
13F Institute Ownership
Total Institutes of 38 in VYNE Therapeutics expanded their positions with an increase of 3 investors compared to the previous quarter. An additional 97.02K shares, as total invested capital declined by $11.96M with ownership percentage increasing from 16.59% to 16.78%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Eventide Asset Management, LLC | 3.27% | 1.39M | +0.00% | 2.37M | 0.05% | May 15, 2025 |
| Citadel Advisors LLC | 2.58% | 1.1M | -10.58% | 1.74M | < 0.01% | May 15, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.